Clinical and Laboratory Characteristics and Mortality in Patients with Liver Cirrhosis

Background: To identify independent clinical and laboratory predictors of 28-day mortality in patients with liver cirrhosis.

Materials and Methods: A prospective cohort study included 137 patients with liver cirrhosis (decompensated cirrhosis without ACLF, n=72; with ACLF, n=65). Univariate and multivariate Cox regression analysis was used to identify independent predictors of 28-day mortality. Three models were built and compared: a comprehensive model (all significant variables), a basic clinical model (CLIF-C OFs, SpO₂/FiO₂, pneumonia, ACLF stages), and an extended laboratory model (basic model + lactate, ammonia, C-reactive protein).

Results: In the univariate analysis, significant predictors of mortality were the severity according to the CLIF-C OFs score, ACLF grades 2 and 3, the presence of pneumonia and urinary tract infection (UTI), elevated levels of lactate, ammonia, C-reactive protein (CRP) and transaminases, as well as decreased SpO₂/FiO₂. In all multivariate models, the following remained independent predictors of an unfavorable outcome: CLIF-C OFs score, ACLF grades 2 and 3, presence of pneumonia, UTI, elevated levels of lactate, ammonia, CRP, and decreased SpO₂/FiO₂.

Conclusion: The short-term prognosis in liver cirrhosis is determined by the severity of organ failure, infectious complications, and markers of metabolic stress and inflammation. A comprehensive approach using the CLIF-C OFs score and monitoring lactate, ammonia, and CRP is necessary for risk stratification, which will allow for optimized patient management.

1. Sepanlou S.G., Safiri S., Bisignano C. et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8.

2. Odom S.R., Howell M.D., Silva G.S. et al. Lactate clearance as a predictor of mortality in trauma patients. J Trauma Acute Care Surg. 2013;74(4):999–1004. doi: 10.1097/TA.0b013e3182858a3e;

3. Vanni S., Viviani G., Baioni M. et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thromboembolism lactate outcome study. Ann Emerg Med. 2013;61(3):330– 338. doi: 10.1016/j.annemergmed.2012.10.022

4. Kuo C.C., Huang C.H., Chang C. et al. Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-onChronic Liver Failure Patients by a Single-Center ICU Experience. J Pers Med. 2021;11(2):79. doi: 10.3390/jpm11020079.

5. Wang X., Zhang M., Xiao J. et al. A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis. QJM. 2023;116(6):436-442. doi: 10.1093/qjmed/hcad076.

6. Nadinskaya M.Yu., Maevskaya M.V., Bakulin I.G. et al. Diagnostic and prognostic significance of hyperammonemia in patients with liver cirrhosis, hepatic encephalopathy and sarcopenia (experts’ agreement). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2024;34(1):85-100. doi: 10.22416/1382-4376-2024-34-1-85-100. [In Russian].

7. Tranah T.H., Ballester M.P., Carbonell-Asins J.A. et al. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. J Hepatol. 2022;77(6):1554-1563. doi: 10.1016/j.jhep.2022.07.014.

8. Fernández J., Acevedo J., Wiest R. et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2017;67(10):1870–1880. doi: 10.1136/gutjnl-2017-314240.

9. Fernández, J., Prado, V., Trebicka J et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. Journal of hepatology. 2019;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027.